Prevalence of low lean mass in patients with adult growth hormone deficiency with or without low-dose growth hormone therapy

Clinical Endocrinology
Xiaoya ZhengWei Ren

Abstract

The importance of muscle mass has been emphasized in various studies, and growth hormone (GH) deficiency is tightly associated with lean mass loss. Therefore, we aimed to investigate the prevalence of low lean mass in patients with adult growth hormone deficiency (AGHD) who received or did not receive GH therapy. In this retrospective study, we included patients diagnosed with AGHD by using the insulin tolerance test (ITT) in our hospital. Patients without completed follow-up data were excluded, and data for 56 patients were analysed. Twenty-six patients who had received GH therapy for more than 6 months, based on the medical record, were included in the GH group and received recombinant human growth hormone (rhGH) at a dose of 0.5 IU/d. Thirty patients who had not previously received GH treatment were included in the non-GH group. Many anthropometric and blood biochemical indicators were measured. Body composition was measured on a dual-energy X-ray-absorptiometry (DXA) scanner. Low lean mass was defined as a skeletal muscle index (SMI) <7.0 kg/m2 in males or 5.7 kg/m2 in females. Statistical analyses were performed using GraphPad Prism 5.0. Compared to the non-GH group, the patients who received GH therapy had significantly l...Continue Reading

References

Mar 27, 1999·Metabolism: Clinical and Experimental·F J HayesT J McKenna
Sep 13, 2000·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·C A Lissett, S M Shalet
May 8, 2002·The Journal of Clinical Endocrinology and Metabolism·Johan SvenssonJan-Ove Johansson
May 6, 2004·The Journal of Clinical Endocrinology and Metabolism·Patrick MaisonUNKNOWN Metaanalysis of Blinded, Randomized, Placebo-Controlled Trials
Sep 4, 2007·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·E GhigoG Corneli
May 27, 2008·British Journal of Pharmacology·C P Velloso
Sep 3, 2008·Mechanisms of Ageing and Development·Silvia GiovanniniChristiaan Leeuwenburgh
Feb 24, 2010·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Kazuo ChiharaKatsuhiko Tachibana
Nov 26, 2010·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Christin SpielhagenHenri Wallaschofski
Nov 16, 2012·European Journal of Endocrinology·Valentina GascoGianluca Aimaretti
Mar 30, 2013·The Journal of Clinical Endocrinology and Metabolism·Shlomo Melmed
Nov 13, 2013·The Journal of Clinical Endocrinology and Metabolism·Carmine GazzarusoAndrea Giustina
Jun 29, 2014·Endocrine·Jörgen IsgaardAntonio Cittadini
Jul 30, 2014·Neurologia Medico-chirurgica·Izumi FukudaAtsuhiro Ichihara
Aug 20, 2015·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Peipei HanKaijun Niu
Apr 29, 2016·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·L ChanL Lan
May 10, 2017·Best Practice & Research. Clinical Endocrinology & Metabolism·Carolina Di SommaAnnamaria Colao
Aug 23, 2017·Scientific Reports·Qingfeng ChengQifu Li
Mar 23, 2018·International Journal of Molecular Sciences·Juan J DíezFernando Cordido
Mar 23, 2018·Journal of Bone Metabolism·Jeong Jae MoonChan-Ho Park
Apr 13, 2018·Lipids in Health and Disease·Xiaoya ZhengYonghong Wang

❮ Previous
Next ❯

Citations

Nov 26, 2019·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Kevin C J YuenAndrew R Hoffman
Sep 3, 2020·The Journal of Clinical Endocrinology and Metabolism·Karlijn PellikaanLaura C G de Graaff

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.